Retrospective Study
Copyright ©The Author(s) 2023.
World J Diabetes. May 15, 2023; 14(5): 594-605
Published online May 15, 2023. doi: 10.4239/wjd.v14.i5.594
Table 2 Basic and clinical characteristics of patients in the no severe intracranial and extracranial artery stenosis, intracranial artery stenosis, severe extracranial artery stenosis and combined severe intracranial and extracranial artery stenosis groups
Characteristics
NOCS group (n = 224)
ICAS group (n = 19)
ECAS group (n = 8)
COAS group (n = 6)
P value
Age (yr)66.0 (11.0)65.0 (16.0)67.5 (13.0)71.0 (10.0)0.373
Male, n (%)103 (46.0)10 (52.6)5 (62.5)3 (50)0.780
Duration of T2DM (yr)12.0 (14.0)15.0 (11.0)18.0 (20.8)11.5 (7.0)0.635
Risk factors, n (%)
Hypertension165 (73.7)13 (68.4)5 (62.5)6 (100)0.527
Hyperlipidemia112 (50.0)4 (21.1)7 (75.0)2 (33.3)0.029
CAD63 (28.3)7 (36.8)2 (25.0)2 (33.3)0.826
Previous stroke22 (9.8)4 (21.1)2 (25.0)3 (50.0)0.009
Current smoker67 (29.9)4 (21.1)1 (12.5)2 (33.3)0.682
Current drinker59 (26.3)4 (21.1)1 (12.5)0 (0)0.554
BMI (kg/m2)25.78 (3.59)26.06 (3.90)25.32 (2.33)23.96 (12.48)0.821
FPG (mmol/L)7.49 (3.53)7.83 (4.13)7.13 (6.89)5.76 (2.48)0.446
HbA1c (%)7.60 (2.60)7.90 (3.10)9.15 (1.70)7.90 (1.80)0.067
INS (µIU/mL)12.00 (10.71)16.99 (19.11)12.78 (19.72)15.90 (25.32)0.334
CP (ng/mL)2.33 (1.53)2.52 (1.45)1.56 (2.95)2.03 (2.31)0.599
TC (mmol/L)4.27 (1.41)3.85 (1.98)4.92 (2.35)4.35 (2.25)0.535
TG (mmol/L)1.50 (1.39)1.59 (1.31)1.29 (1.31)1.16 (1.85)0.585
LDL-C (mmol/L)2.39 (1.20)2.27 (1.76)2.62 (1.88)2.01 (2.27)0.943
HDL-C (mmol/L)1.13 (0.47)0.98 (0.29)1.25 (1.21)1.04 (0.43)0.170
Scr (µmol/L)62.0 (22.8)59.0 (48.0)78.5 (44.8)60.0 (40.3)0.499
Bun (mmol/L)5.92 (2.12)6.36 (2.74)7.92 (6.76)6.57 (5.00)0.419
UA (µmol/L)342.0 (127.3)358.0 (174.0)322.5 (153.3)303.0 (136.3)0.746
OC (ng/mL)10.27 (5.87)12.76 (8.14)11.89 (4.02)15.15 (11.43)0.012
CTX (pg/mL)0.29 (0.19)0.41 (0.29)0.35 (0.23)0.65 (0.51)0.027
PINP (pg/mL)33.39 (20.37)41.25 (24.71)47.22 (39.85)51.28 (37.96)0.059